ALGN vs. WST, COO, MMSI, HAE, ICUI, XRAY, QDEL, NEOG, STAA, and CERS
Should you be buying Align Technology stock or one of its competitors? The main competitors of Align Technology include West Pharmaceutical Services (WST), Cooper Companies (COO), Merit Medical Systems (MMSI), Haemonetics (HAE), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), Neogen (NEOG), STAAR Surgical (STAA), and Cerus (CERS). These companies are all part of the "health care supplies" industry.
Align Technology vs.
Align Technology (NASDAQ:ALGN) and West Pharmaceutical Services (NYSE:WST) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, community ranking, risk, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.
88.4% of Align Technology shares are held by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are held by institutional investors. 0.7% of Align Technology shares are held by company insiders. Comparatively, 0.5% of West Pharmaceutical Services shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
In the previous week, West Pharmaceutical Services had 27 more articles in the media than Align Technology. MarketBeat recorded 34 mentions for West Pharmaceutical Services and 7 mentions for Align Technology. Align Technology's average media sentiment score of 1.62 beat West Pharmaceutical Services' score of 0.31 indicating that Align Technology is being referred to more favorably in the media.
Align Technology received 525 more outperform votes than West Pharmaceutical Services when rated by MarketBeat users. Likewise, 69.73% of users gave Align Technology an outperform vote while only 56.20% of users gave West Pharmaceutical Services an outperform vote.
West Pharmaceutical Services has a net margin of 17.03% compared to Align Technology's net margin of 10.54%. West Pharmaceutical Services' return on equity of 18.60% beat Align Technology's return on equity.
West Pharmaceutical Services has lower revenue, but higher earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.
Align Technology currently has a consensus price target of $241.25, suggesting a potential upside of 33.34%. West Pharmaceutical Services has a consensus price target of $332.50, suggesting a potential upside of 48.51%. Given West Pharmaceutical Services' stronger consensus rating and higher probable upside, analysts clearly believe West Pharmaceutical Services is more favorable than Align Technology.
Align Technology has a beta of 1.64, suggesting that its stock price is 64% more volatile than the S&P 500. Comparatively, West Pharmaceutical Services has a beta of 1.09, suggesting that its stock price is 9% more volatile than the S&P 500.
Summary
West Pharmaceutical Services beats Align Technology on 11 of the 18 factors compared between the two stocks.
Get Align Technology News Delivered to You Automatically
Sign up to receive the latest news and ratings for ALGN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Align Technology Competitors List
Related Companies and Tools
This page (NASDAQ:ALGN) was last updated on 6/10/2025 by MarketBeat.com Staff
Buy ALGN Stock Free ALGN Stock Alerts